We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The international effort to chart the proteome — all the proteins in the human body — is gathering pace, driven by the need for better diagnosis and treatment of diseases. Now China, which is spearheading the Human Liver Proteome Project (HLPP), is pledging US$250 million to the cause if its labs make it to the production phase.

This article explains how China’s project is just one component of the Human Proteome Organisation (HUPO), which is also overseeing work by the United States on human blood plasma, and by Germany on the brain. So far, 37 Chinese labs have signed on to the HLPP, and the production phase is expected to begin in 2006.

The HLPP aims to link liver proteins to liver diseases, which kill hundreds of thousands in China every year. While experts say that confirming this will take more samples than the projects will be able to handle, HUPO’s fourth initiative could come to the rescue. Its proposed library of antibodies could do the tracking for them.
Link to full Science article

Reference: Science, 302, 1316 (2003)